Al-Chalabi, A., Andersen, P. M., Chandran, S., Chio, A., Corcia, P., Couratier, P., Danielsson, O., de Carvalho, M., Desnuelle, C., Grehl, T., Grosskreutz, J., Holmøy, T., Ingre, C., Karlsborg, M., Kleveland, G., Christoph Koch, J., Koritnik, B., KuzmaKozakiewicz, M., Laaksovirta, H., Ludolph, A., McDermott, C., Meyer, T., Mitre Ropero, B., Mora Pardina, J., Nygren, I., Petri, S., Povedano Panades, M., Salachas, F., Shaw, P., Silani, V., Staaf, G., Svenstrup, K., Talbot, K., Tysnes, O., Van Damme, P., van der Kooi, A., Weber, M., Weydt, P., Wolf, J., Hardiman, O., & van den Berg, L. H. (2017). july 2017 ENCALS statement on edaravone. Amyotrophic lateral sclerosis and frontotemporal degeneration, 18(7), 471–474. http://access.bl.uk/ark:/81055/vdc_100053607298.0x000012